Fluorescence Immunohistochemistry Techniques for Labeling Metabotropic Glutamate Receptors in the Central Nervous System

2021 ◽  
pp. 227-242
Author(s):  
Ryan S. Pevey ◽  
Jonna M. Leyrer-Jackson ◽  
Erin Nagy ◽  
M. Foster Olive
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Glutamate Receptors ◽  
Metabotropic Glutamate Receptors ◽  
Metabotropic Glutamate ◽  
The Central Nervous System ◽  
Fluorescence Immunohistochemistry

scholarly journals Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system

2018 ◽  
Vol 128 ◽  
pp. 301-313 ◽  
Author(s):  
Luisa Di Menna ◽  
Max E. Joffe ◽  
Luisa Iacovelli ◽  
Rosamaria Orlando ◽  
Craig W. Lindsley ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Glutamate Receptors ◽  
Metabotropic Glutamate Receptors ◽  
Metabotropic Glutamate ◽  
The Central Nervous System

scholarly journals Experience with newer central nervous system autoantibodies

2017 ◽  
Vol 55 (1) ◽  
pp. 7-17 ◽  
Author(s):  
AR Karim ◽  
S Jacob
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Glutamate Receptors ◽  
Metabotropic Glutamate Receptors ◽  
Glycine Receptor ◽  
Neuronal Cell ◽  
Acid Decarboxylase ◽  
Substantial Impact ◽  
Metabotropic Glutamate ◽  
Dopamine 2 Receptor

In the last decade, a large number of neuronal cell-surface antibodies have been described which are responsible for a range of neuroimmunological central nervous system disorders. Unlike the paraneoplastic antibodies which target intracellular antigens, these antibodies appear to be pathogenic and hence identification and prompt treatment can make a substantial impact on clinical outcomes of these patients. We review the common antibodies against the ionotropic glutamate receptors (NMDAR, AMPAR), metabotropic glutamate receptors (mGluR1 and mGluR5), voltage-gated potassium channel-complex proteins (LGI1, CASPR2), and other antibodies targeted against glycine receptor, glutamic acid decarboxylase, gamma-amino butyric acid B, dopamine-2-receptor and dipeptidyl-peptidase-like protein 6.

Metabotropic Glutamate Receptors in Central Nervous System Diseases

2016 ◽  
Vol 17 (5) ◽  
pp. 538-616 ◽  
Author(s):  
Anna V. Golubeva ◽  
Rachel D. Moloney ◽  
Richard M. O';Connor ◽  
Timothy G. Dinan ◽  
John F. Cryan
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Glutamate Receptors ◽  
Metabotropic Glutamate Receptors ◽  
Nervous System Diseases ◽  
Central Nervous System Diseases ◽  
Metabotropic Glutamate
Sign in / Sign up

Export Citation Format

Share Document